These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 29310330)

  • 21. Efficacy and safety of catheter ablation combined with left atrial appendage occlusion for nonvalvular atrial fibrillation: A systematic review and meta-analysis.
    Jiang Y; Li F; Li D; Cheng Y; Jia Y; Fu H; Pu X; Hu H; Jiang J; Zeng R
    Pacing Clin Electrophysiol; 2020 Jan; 43(1):123-132. PubMed ID: 31721242
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stroke and Cardiovascular Events After Ablation or Antiarrhythmic Drugs for Treatment of Patients With Atrial Fibrillation.
    Mansour M; Heist EK; Agarwal R; Bunch TJ; Karst E; Ruskin JN; Mahapatra S
    Am J Cardiol; 2018 May; 121(10):1192-1199. PubMed ID: 29571722
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oral anticoagulation after catheter ablation of atrial fibrillation and the associated risk of thromboembolic events and intracranial hemorrhage: A systematic review and meta-analysis.
    Romero J; Cerrud-Rodriguez RC; Diaz JC; Rodriguez D; Arshad S; Alviz I; Cerna L; Rios S; Monhanty S; Natale A; Garcia MJ; Di Biase L
    J Cardiovasc Electrophysiol; 2019 Aug; 30(8):1250-1257. PubMed ID: 31257677
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Catheter ablation for paroxysmal and persistent atrial fibrillation.
    Chen HS; Wen JM; Wu SN; Liu JP
    Cochrane Database Syst Rev; 2012 Apr; 2012(4):CD007101. PubMed ID: 22513945
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk factors for thromboembolic and bleeding events in anticoagulated patients with atrial fibrillation: the prospective, multicentre observational PREvention oF thromboembolic events - European Registry in Atrial Fibrillation (PREFER in AF).
    Rohla M; Weiss TW; Pecen L; Patti G; Siller-Matula JM; Schnabel RB; Schilling R; Kotecha D; Lucerna M; Huber K; De Caterina R; Kirchhof P
    BMJ Open; 2019 Mar; 9(3):e022478. PubMed ID: 30928922
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Very low risk of thromboembolic events in patients undergoing successful catheter ablation of atrial fibrillation with a CHADS2 score ≤3: a long-term outcome study.
    Saad EB; d'Avila A; Costa IP; Aryana A; Slater C; Costa RE; Inácio LA; Maldonado P; Neto DM; Camiletti A; Camanho LE; Polanczyk CA
    Circ Arrhythm Electrophysiol; 2011 Oct; 4(5):615-21. PubMed ID: 21841192
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of catheter ablation for atrial fibrillation in heart failure: a meta-analysis of randomized controlled trials.
    Zhang Z; Zheng Y; He W; Wei J; Li P; Zhong G; Jiang Z
    ESC Heart Fail; 2024 Oct; 11(5):2684-2693. PubMed ID: 38661235
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessment of Catheter Ablation or Antiarrhythmic Drugs for First-line Therapy of Atrial Fibrillation: A Meta-analysis of Randomized Clinical Trials.
    Turagam MK; Musikantow D; Whang W; Koruth JS; Miller MA; Langan MN; Sofi A; Choudry S; Dukkipati SR; Reddy VY
    JAMA Cardiol; 2021 Jun; 6(6):697-705. PubMed ID: 33909022
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Catheter ablation of atrial fibrillation in the elderly: does the benefit outweigh the risk?
    Kennedy R; Oral H
    Expert Rev Cardiovasc Ther; 2013 Jun; 11(6):697-704. PubMed ID: 23750679
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Surgical versus catheter ablation in atrial fibrillation: A systematic review and meta-analysis of randomized controlled trials.
    Rattanawong P; Kanitsoraphan C; Kewcharoen J; Sriramoju A; Shanbhag A; Ko Ko NL; Barry T; Vutthikraivit W; Shen WK
    J Cardiovasc Electrophysiol; 2022 Oct; 33(10):2152-2163. PubMed ID: 35771487
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Early cerebral thromboembolic complications after radiofrequency catheter ablation of atrial fibrillation: incidence, characteristics, and risk factors.
    Kosiuk J; Kornej J; Bollmann A; Piorkowski C; Myrda K; Arya A; Sommer P; Richter S; Rolf S; Husser D; Gaspar T; Lip GY; Hindricks G
    Heart Rhythm; 2014 Nov; 11(11):1934-40. PubMed ID: 25086257
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Strategy Optimization for a Combined Procedure in Patients With Atrial Fibrillation: The COMBINATION Randomized Clinical Trial.
    Du X; Chu H; Yang B; Zhong J; Ruan Z; Chen Q; Leng B; Tao S; Lai H; Liang J; Xie R; Ye P; Zhou X; Li Y; Li J; Zhao Y; Zou C; Sun H; Li X; Rong B; Chen G; Hu J; Jia J; Fang Y; Xia Z; Liu Q; Zuo T; Zhu X; Xu L; Yang S; Luo C; Shen C; Feng M; Jiang Y; Fu G; Wang B; Yu X; Chen X;
    JAMA Netw Open; 2024 Nov; 7(11):e2445084. PubMed ID: 39546313
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-Term Outcomes of Left Atrial Appendage Electrical Isolation in Patients With Nonparoxysmal Atrial Fibrillation: A Propensity Score-Matched Analysis.
    Romero J; Di Biase L; Mohanty S; Trivedi C; Patel K; Parides M; Alviz I; Diaz JC; Natale V; Sanchez J; Della Rocca DG; Yang R; Mohanty P; Gianni C; Horton R; Burkhardt D; Al-Ahmad A; Lakkireddy D; Natale A
    Circ Arrhythm Electrophysiol; 2020 Nov; 13(11):e008390. PubMed ID: 32998529
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Uninterrupted anticoagulation with non-vitamin K antagonist oral anticoagulants in atrial fibrillation catheter ablation: Lessons learned from randomized trials.
    Cardoso R; Willems S; Gerstenfeld EP; Verma A; Schilling R; Hohnloser SH; Okumura K; Nordaby M; Brouwer MA; Calkins H
    Clin Cardiol; 2019 Jan; 42(1):198-205. PubMed ID: 30460702
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Anticoagulation in high thromboembolic risk after catheter ablation for atrial fibrillation: results from the German Ablation Registry].
    Moser J; Kuck KH; Andresen D; Spitzer SG; Hoffmann E; Schumacher B; Eckardt L; Brachmann J; Lewalter T; Hochadel M; Senges J; Willems S; Hoffmann BA
    Dtsch Med Wochenschr; 2014 Sep; 139(39):1923-8. PubMed ID: 25225860
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Thromboembolic and bleeding risks in patients undergoing atrial fibrillation ablation: oral anticoagulation perspectives.
    Briceño DF; Madan N; Romero J; Londoño A; Villablanca PA; Natale A; Di Biase L
    Expert Opin Drug Saf; 2017 Jul; 16(7):769-777. PubMed ID: 28475380
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Curative catheter ablation in atrial fibrillation and typical atrial flutter: systematic review and economic evaluation.
    Rodgers M; McKenna C; Palmer S; Chambers D; Van Hout S; Golder S; Pepper C; Todd D; Woolacott N
    Health Technol Assess; 2008 Nov; 12(34):iii-iv, xi-xiii, 1-198. PubMed ID: 19036232
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Uninterrupted versus interrupted direct oral anticoagulation for catheter ablation of atrial fibrillation: A systematic review and meta-analysis.
    Asad ZUA; Akhtar KH; Jafry AH; Khan MH; Khan MS; Munir MB; Lakkireddy DR; Gopinathannair R
    J Cardiovasc Electrophysiol; 2021 Jul; 32(7):1995-2004. PubMed ID: 33861494
    [TBL] [Abstract][Full Text] [Related]  

  • 39. R2CHADS2 score and thromboembolic events after catheter ablation of atrial fibrillation in comparison with the CHA2DS2-VASc score.
    Chao TF; Lin YJ; Chang SL; Lo LW; Hu YF; Tuan TC; Liao JN; Chung FP; Hsieh MH; Chen SA
    Can J Cardiol; 2014 Apr; 30(4):405-12. PubMed ID: 24582725
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Apixaban versus Warfarin for the Prevention of Periprocedural Cerebral Thromboembolism in Atrial Fibrillation Ablation: Multicenter Prospective Randomized Study.
    Kuwahara T; Abe M; Yamaki M; Fujieda H; Abe Y; Hashimoto K; Ishiba M; Sakai H; Hishikari K; Takigawa M; Okubo K; Takagi K; Tanaka Y; Nakajima J; Takahashi A
    J Cardiovasc Electrophysiol; 2016 May; 27(5):549-54. PubMed ID: 26766541
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.